Geneprodx

📍 Santiago, Chile🗓 Founded 2014👥 27 employees💰 Last funded 2015
Biotechnology Research🌐 thyroidprint.com
Website LinkedIn
Geneprodx us a clinical laboratory devoted to the molecular diagnostic of thyroid cancer. Geneprodx developed ThyroidPrint®, a test the will prevent 88% of unnecessary surgery practiced on patients with an undetermined diagnostic. ThyroidPrint® is the only genetic test for thyroid cancer that has been validated in two independent clinical trials: USA and Chile. Geneprodx is a spin-off from the Pontifical Catholic University of Chile and is the first chilean clinical laboratory to be accredited by the College of American Patologists (CAP). Visit our ThyroidPrint® website. There you may find all the information that patients and physicians need about this test.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Chile
1
Frequently asked questions
Who invested in Geneprodx?
Geneprodx has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Geneprodx last raise funding?
The most recent investment in Geneprodx recorded on gritt.io was in 2015.
When was Geneprodx founded?
Geneprodx was founded in 2014.
What industry is Geneprodx in?
Geneprodx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Geneprodx based?
Geneprodx is headquartered in Santiago, Chile.